Aura Biosciences Inc (AURA) — Cash Flow-to-Debt Ratio
Aura Biosciences Inc (AURA) has a Cash Flow-to-Debt Ratio of -0.60x as of September 2025, meaning its operating cash flow of $-20.14 Million could theoretically repay -1% of its total liabilities ($33.36 Million) in one year. See AURA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aura Biosciences Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Aura Biosciences Inc across 6 annual periods. Also explore AURA net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Aura Biosciences Inc (2019–2024)
Year-by-year debt coverage analysis for Aura Biosciences Inc. For market capitalisation and broader financial context, see market value of Aura Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.61x | $-79.81 Million | $30.53 Million | ▼ -19.6% |
| 2023 | -2.18x | $-63.85 Million | $29.23 Million | ▼ -13.4% |
| 2022 | -1.93x | $-54.60 Million | $28.35 Million | ▲ +54.2% |
| 2021 | -4.20x | $-32.41 Million | $7.71 Million | ▲ +52.7% |
| 2020 | -8.87x | $-24.32 Million | $2.74 Million | ▼ -170.1% |
| 2019 | -3.28x | $-20.67 Million | $6.29 Million | — |